April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are ...
April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to ...
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder ...
March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...
March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...